Elucidating the precise pharmacological system of action (MOA) of Normally taking place compounds is often complicated. While Tarselli et al. (60) designed the first de novo synthetic pathway to conolidine and showcased this Normally happening compound correctly suppresses responses to both chemically induced and inflammation-derived pain, the phar… Read More